Literature DB >> 3084535

Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.

A M Matsumoto, A E Karpas, W J Bremner.   

Abstract

The role of FSH in the maintenance of spermatogenesis in man is poorly understood. To determine whether normal serum levels of FSH are necessary for the maintenance of quantitatively normal spermatogenesis, we first studied the effect on sperm production of selective FSH deficiency induced by chronic administration of hCG in normal men. Then, we determined the effect of FSH replacement in some of these men. After a 3-month control period, eight normal men (aged 30-39 yr) received 5000 IU hCG, im, twice weekly for 7 months. Then while continuing the same dosage of hCG, subjects simultaneously received 200 mg testosterone enanthate (T), im, weekly for an additional 6 months. hCG administration alone resulted in partial suppression of the mean sperm concentration from 88 +/- 24 (+/-SEM) million/ml during the control period to 22 +/- 7 million/ml during the last 4 months of hCG treatment (P less than 0.001 compared to control values). With the addition of T to hCG, sperm counts remained suppressed to the same degree. Except for one man who became azoospermic while receiving hCG plus T, sperm motilities and morphologies remained normal in all subjects throughout the entire study. During both the hCG alone and hCG plus T periods, serum FSH levels were undetectable (less than 25 ng/ml), and urinary FSH levels were comparable to those in prepubertal children and hypogonadotropic hypogonadal adults. We replaced FSH activity in four of the eight men in whom prolonged selective FSH deficiency and partial suppression of sperm production were induced by hCG administration. Immediately after the period of hCG plus T administration, T was stopped in four men who continued to receive hCG alone (5000 IU, im, twice weekly) for 3 months. Then, while continuing the same dosage of hCG, these men received 100 IU human FSH, sc, daily (n = 2) or 75 IU human menopausal gonadotropin, sc, daily (n = 2) for 5-8 months. During the second period of hCG administration alone, serum FSH levels were undetectable (less than 25 ng/ml), and sperm concentrations were suppressed (34 +/- 13 million/ml) compared to the control values for these four men (125 +/- 39 million/ml; P less than 0.001). With the addition of FSH to hCG, FSH levels increased (213 +/- 72 ng/ml) and sperm concentrations rose significantly, reaching a mean of 103 +/- 30 million/ml (P less than 0.03 compared to hCG alone).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084535     DOI: 10.1210/jcem-62-6-1184

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

Review 1.  Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

Authors:  Claire Bouvattier; Luigi Maione; Jérôme Bouligand; Catherine Dodé; Anne Guiochon-Mantel; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

2.  Effect of hCG or hCG+ treatments in young thalassemic patients with hypogonadotropic hypogonadism.

Authors:  R Balducci; V Toscano; G Finocchi; G Municchi; A Mangiantini; B Boscherini
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

Review 3.  Approach to male infertility and induction of spermatogenesis.

Authors:  Bradley D Anawalt
Journal:  J Clin Endocrinol Metab       Date:  2013-09       Impact factor: 5.958

4.  Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism.

Authors:  A A Sinisi; D Esposito; G Bellastella; L Maione; V Palumbo; L Gandini; F Lombardo; A De Bellis; A Lenzi; A Bellastella
Journal:  J Endocrinol Invest       Date:  2010-04-30       Impact factor: 4.256

Review 5.  Follicle-stimulating hormone treatment in normogonadotropic infertile men.

Authors:  Daniela Valenti; Sandro La Vignera; Rosita A Condorelli; Rocco Rago; Nunziata Barone; Enzo Vicari; Aldo E Calogero
Journal:  Nat Rev Urol       Date:  2012-12-11       Impact factor: 14.432

6.  Effect of copper exposure on reproductive ability in the bank vole (Myodes glareolus).

Authors:  Agata Miska-Schramm; Małgorzata Kruczek; Joanna Kapusta
Journal:  Ecotoxicology       Date:  2014-08-07       Impact factor: 2.823

7.  Focal disruption of spermatogenesis in the testis of adult rats after a single administration of human chorionic gonadotrophin.

Authors:  J B Kerr; R M Sharpe
Journal:  Cell Tissue Res       Date:  1989-07       Impact factor: 5.249

Review 8.  Neuropeptides of the pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide/growth hormone-releasing hormone/secretin family in testis.

Authors:  Min Li; Akira Arimura
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

Review 9.  FSHbeta knockout mouse model: a decade ago and into the future.

Authors:  T Rajendra Kumar
Journal:  Endocrine       Date:  2009-04-23       Impact factor: 3.633

10.  Relative roles of follicle-stimulating hormone and luteinizing hormone in the control of inhibin secretion in normal men.

Authors:  R I McLachlan; A M Matsumoto; H G Burger; D M de Kretser; W J Bremner
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.